Colgate-Palmolive Company (CL) Bundle
Understanding Colgate-Palmolive Company (CL) Revenue Streams
Understanding Colgate-Palmolive Company’s Revenue Streams
The total worldwide net sales for the third quarter of 2024 amounted to $5,033 million, reflecting a year-over-year increase of 2.4% from $4,917 million in the third quarter of 2023. This was driven by volume growth of 3.7% and net selling price increases of 3.1%, though partially offset by negative foreign exchange impacts of 4.4%.
Breakdown of Primary Revenue Sources
Revenue is generated primarily from two segments: Oral, Personal and Home Care, and Pet Nutrition. The net sales breakdown for the third quarter of 2024 is as follows:
| Segment | Net Sales (Q3 2024, $ Million) | Year-over-Year Change (%) |
|---|---|---|
| Oral, Personal and Home Care | $3,907 | +1.3% |
| Hill’s Pet Nutrition | $1,126 | +6.3% |
| Total | $5,033 | +2.4% |
For the first nine months of 2024, total worldwide net sales reached $15,156 million, up 4.5% from $14,507 million in the same period of 2023.
Year-over-Year Revenue Growth Rate
Year-over-year revenue growth rates are as follows:
- Q3 2024 vs Q3 2023: 2.4%
- First nine months of 2024 vs 2023: 4.5%
Organic sales growth, excluding foreign exchange impacts, was reported at 6.8% for the third quarter.
Contribution of Different Business Segments to Overall Revenue
During the third quarter of 2024, the contributions from each segment to overall revenue were:
| Segment | Net Sales (Q3 2024, $ Million) | Percentage of Total Revenue (%) |
|---|---|---|
| Oral, Personal and Home Care | $3,907 | 77.6% |
| Hill’s Pet Nutrition | $1,126 | 22.4% |
Analysis of Significant Changes in Revenue Streams
Notable changes in revenue streams during the third quarter include:
- Decrease in net sales in North America by 2.1% to $1,004 million due to lower selling prices and negative foreign exchange.
- Increase in Latin America net sales by 3.3% driven by a 14.2% increase in organic sales.
- Growth in Europe net sales by 8.0% to $744 million, attributed to volume growth and favorable foreign exchange.
- Significant growth in the Pet Nutrition segment, which increased by 6.3%.
Overall, the revenue trends indicate a diverse performance across regions and segments, with some areas experiencing growth while others faced challenges due to market conditions.
A Deep Dive into Colgate-Palmolive Company (CL) Profitability
A Deep Dive into Colgate-Palmolive Company's Profitability
Gross Profit Margin: In the third quarter of 2024, the worldwide gross profit margin increased to 61.1% from 58.5% in the third quarter of 2023. For the first nine months of 2024, the gross profit margin was 60.6%, up from 57.7% in the same period of 2023.
| Period | Gross Profit (GAAP) | Gross Profit Margin (GAAP) | Gross Profit (Non-GAAP) | Gross Profit Margin (Non-GAAP) |
|---|---|---|---|---|
| Q3 2024 | $3,074 million | 61.1% | $3,083 million | 61.3% |
| Q3 2023 | $2,877 million | 58.5% | $2,878 million | 58.6% |
| 9M 2024 | $9,179 million | 60.6% | $9,198 million | 60.7% |
| 9M 2023 | $8,376 million | 57.7% | $8,377 million | 57.7% |
Operating Profit: Operating profit for the third quarter of 2024 was $1,065 million, a 4% increase from $1,029 million in Q3 2023. For the first nine months of 2024, operating profit was $3,205 million, up 10% from $2,912 million in the same period of 2023.
Operating Profit Margin: The operating profit margin for Q3 2024 was 21.2%, an increase of 30 basis points from 20.9% in Q3 2023. For the first nine months of 2024, the operating profit margin was 21.1%, up 100 basis points from 20.1% in the first nine months of 2023.
| Period | Operating Profit (GAAP) | Operating Profit Margin (GAAP) | Operating Profit (Non-GAAP) | Operating Profit Margin (Non-GAAP) |
|---|---|---|---|---|
| Q3 2024 | $1,065 million | 21.2% | $1,080 million | 21.5% |
| Q3 2023 | $1,029 million | 20.9% | $1,031 million | 21.0% |
| 9M 2024 | $3,205 million | 21.1% | $3,282 million | 21.7% |
| 9M 2023 | $2,912 million | 20.1% | $2,962 million | 20.4% |
Net Profit: Net income attributable to the company for Q3 2024 was $737 million, an increase from $708 million in Q3 2023. For the first nine months of 2024, net income was $2,150 million, compared to $1,582 million for the same period in 2023.
Earnings Per Share (EPS): Diluted EPS for Q3 2024 was $0.90, up from $0.86 in Q3 2023. For the first nine months of 2024, diluted EPS was $2.61, compared to $1.90 for the first nine months of 2023.
| Period | Net Income | Diluted EPS |
|---|---|---|
| Q3 2024 | $737 million | $0.90 |
| Q3 2023 | $708 million | $0.86 |
| 9M 2024 | $2,150 million | $2.61 |
| 9M 2023 | $1,582 million | $1.90 |
Comparison with Industry Averages: The operating profit margin of 21.1% for the first nine months of 2024 is above the industry average of approximately 18% to 20%. The gross profit margin of 60.6% also exceeds the industry average of around 50% to 55%.
Trends in Profitability: The company has shown consistent improvement in profitability metrics over the past year, with notable increases in both gross and operating profit margins. The increase in operational efficiency is attributed to effective cost management and pricing strategies.
Debt vs. Equity: How Colgate-Palmolive Company (CL) Finances Its Growth
Debt vs. Equity: How Colgate-Palmolive Company Finances Its Growth
Long-term debt as of September 30, 2024, decreased to $7,929 million from $8,239 million as of December 31, 2023. Total debt as of September 30, 2024, was $8,436 million, down from $8,549 million at the end of 2023 .
The debt-to-equity ratio stood at 1.85 as of September 30, 2024, compared to an industry average of approximately 1.00. This indicates a higher reliance on debt financing relative to equity compared to industry peers .
In the first quarter of 2024, the company redeemed $500 million of ten-year Medium-Term Notes with a fixed coupon of 3.25%, financed through commercial paper borrowings . The company maintains a robust credit profile, with a credit rating of A- from S&P and A3 from Moody's .
As of September 30, 2024, domestic commercial paper outstanding was $1,282 million, while foreign commercial paper was $906 million . The average daily balance for commercial paper in the first nine months of 2024 was $1,754 million .
The company has a strong focus on balancing its financing strategy, reflecting a mix of debt financing and equity funding. It has increased its quarterly common stock dividend to $0.50 per share from $0.48, demonstrating confidence in its cash flow generation .
| Financial Metric | Value (as of September 30, 2024) |
|---|---|
| Long-term Debt | $7,929 million |
| Total Debt | $8,436 million |
| Debt-to-Equity Ratio | 1.85 |
| Commercial Paper Outstanding (Domestic) | $1,282 million |
| Commercial Paper Outstanding (Foreign) | $906 million |
| Average Daily Balance for Commercial Paper | $1,754 million |
| Quarterly Common Stock Dividend | $0.50 per share |
| Credit Rating (S&P) | A- |
| Credit Rating (Moody's) | A3 |
Assessing Colgate-Palmolive Company (CL) Liquidity
Assessing Colgate-Palmolive Company's Liquidity
Current Ratio: As of September 30, 2024, the current ratio is 1.1, indicating that current assets exceed current liabilities, which suggests a stable liquidity position.
Quick Ratio: The quick ratio stands at 0.8, reflecting a solid ability to meet short-term obligations without relying on inventory sales.
Analysis of Working Capital Trends
The working capital as a percentage of net sales is (3.6%) as of September 30, 2024, down from (2.1%) in the same period in 2023. This indicates an increasing reliance on short-term liabilities relative to sales.
| Period | Working Capital (% of Net Sales) |
|---|---|
| September 30, 2024 | (3.6%) |
| September 30, 2023 | (2.1%) |
Cash Flow Statements Overview
Operating Cash Flow: Net cash provided by operations increased by 9% to $2,838 million in the first nine months of 2024, compared to $2,609 million in the same period of 2023.
Investing Cash Flow: Cash used in investing activities was $454 million in the first nine months of 2024, down from $599 million in 2023.
Financing Cash Flow: Cash used in financing activities increased to $2,110 million in the first nine months of 2024 from $1,801 million in 2023.
| Cash Flow Type | 2024 (First 9 Months) | 2023 (First 9 Months) |
|---|---|---|
| Operating Cash Flow | $2,838 million | $2,609 million |
| Investing Cash Flow | ($454 million) | ($599 million) |
| Financing Cash Flow | ($2,110 million) | ($1,801 million) |
Potential Liquidity Concerns or Strengths
Despite a positive current ratio, the quick ratio below 1 indicates potential liquidity concerns, especially in times of financial stress. The decreasing working capital trend may suggest tighter liquidity conditions going forward. However, the increase in operating cash flow reflects a strong cash generation capability, providing some cushion against liquidity pressures.
Long-term Debt: Long-term debt decreased to $7,929 million as of September 30, 2024, from $8,239 million at the end of 2023.
Total Debt: Total debt was reported at $8,436 million as of September 30, 2024, down from $8,549 million at the end of 2023.
Is Colgate-Palmolive Company (CL) Overvalued or Undervalued?
Valuation Analysis
To determine whether the company is overvalued or undervalued, we will analyze key valuation metrics including price-to-earnings (P/E), price-to-book (P/B), and enterprise value-to-EBITDA (EV/EBITDA) ratios, along with stock price trends, dividend yield, and analyst consensus.
Price-to-Earnings (P/E) Ratio
The current P/E ratio stands at 28.8, reflecting a significant premium compared to the industry average of 22.5.
Price-to-Book (P/B) Ratio
The P/B ratio is currently 12.4, indicating that the stock is trading at a substantial premium over its book value of $1.80 per share.
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio is reported at 17.5, which is higher than the sector average of 14.2.
Stock Price Trends
Over the last 12 months, the stock price has experienced fluctuations:
- 12-month high: $89.00
- 12-month low: $72.50
- Current price: $78.50
Dividend Yield and Payout Ratios
The current dividend yield is 2.5%, with a payout ratio of 62% based on the earnings per share of $2.61.
Analyst Consensus
Analyst ratings indicate a consensus of Hold, with 45% recommending a buy, 40% suggesting hold, and 15% rating sell.
| Metric | Value | Industry Average |
|---|---|---|
| P/E Ratio | 28.8 | 22.5 |
| P/B Ratio | 12.4 | N/A |
| EV/EBITDA Ratio | 17.5 | 14.2 |
| 12-Month High | $89.00 | N/A |
| 12-Month Low | $72.50 | N/A |
| Current Price | $78.50 | N/A |
| Dividend Yield | 2.5% | N/A |
| Payout Ratio | 62% | N/A |
| Analyst Consensus | Hold | N/A |
Key Risks Facing Colgate-Palmolive Company (CL)
Key Risks Facing Colgate-Palmolive Company
The financial health of the company is influenced by various internal and external risk factors, which can impact its performance and market position. Below are the significant risks identified:
Industry Competition
The marketplace remains highly competitive, with increased activity from strong local competitors and large multinational companies. The company faces challenges from aggressive product claims and marketing strategies, which can lead to higher promotional spending and pressure on market share.
Regulatory Changes
Changes in regulations, particularly in markets outside the U.S., can affect operational costs and compliance. The company must navigate varying regulations that may impact pricing strategies and product formulations.
Market Conditions
Current global macroeconomic conditions, including inflation and high interest rates, have negatively impacted consumer purchasing patterns. Approximately two-thirds of the company’s net sales originate from international markets, exposing it to volatile foreign currency fluctuations, particularly in hyperinflationary economies like Argentina and Türkiye.
Operational Risks
The company’s operational efficiency is at risk due to increased raw and packaging material costs. In the third quarter of 2024, the gross profit margin decreased by 150 bps due to these higher costs.
Financial Risks
In the first nine months of 2024, the net income attributable to the company was $2,150 million, an increase from $1,582 million in the prior year. However, the effective income tax rate decreased to 23.4% from 29.5% in the same period, reflecting potential financial instability.
Strategic Risks
Strategically, the company is focused on driving organic sales growth. However, the pressures from inflation and shifting consumer preferences towards lower-priced products may hinder these initiatives . The company has incurred pretax costs of $15 million related to its 2022 Global Productivity Initiative.
| Risk Factor | Details | Financial Impact |
|---|---|---|
| Industry Competition | Increased competition from local and multinational firms | Pressure on market share and promotional spending |
| Regulatory Changes | Varied regulations in international markets | Impact on pricing and compliance costs |
| Market Conditions | Inflation and high interest rates affecting consumer spending | Potential decline in sales volumes |
| Operational Risks | Higher raw material costs | Gross profit margin decreased by 150 bps |
| Financial Risks | Net income increased to $2,150 million | Effective tax rate decreased to 23.4% |
| Strategic Risks | Focus on organic sales growth amidst market pressures | Pretax costs of $15 million from productivity initiatives |
The company is actively monitoring these risks and has implemented strategies to mitigate their impact. These include cost-saving initiatives and adjustments to pricing strategies to maintain competitive positioning in the market.
Future Growth Prospects for Colgate-Palmolive Company (CL)
Future Growth Prospects for Colgate-Palmolive Company
Key Growth Drivers
Colgate-Palmolive Company is poised for growth through several strategic initiatives and market dynamics. The company is focusing on product innovations, market expansions, and acquisitions to drive future revenues.
Product Innovations
The company has invested significantly in product innovation, particularly in the Oral Care segment, which holds a 41.6% share of the global toothpaste market, an increase of 0.5 percentage points from the previous year. Innovations in manual toothbrushes have also contributed to a market share of 32.3%, up 0.9 percentage points year-over-year. This emphasis on innovation is expected to enhance product offerings and attract new customers.
Market Expansions
Colgate-Palmolive is actively expanding its presence in key international markets. In the first nine months of 2024, net sales in Latin America increased by 6.6%, driven by organic sales growth of 19.4%. The company is also seeing growth in Europe, with net sales up 8.6% in the same period. These expansions are critical as they tap into emerging markets with increasing demand for consumer goods.
Acquisitions
The company has been strategic about acquisitions to bolster its product lines and market reach. While specific acquisitions were not detailed in the latest reports, the focus remains on integrating high-growth categories that align with consumer trends. The Hill’s Pet Nutrition segment, which generated net sales of $3.342 billion in the first nine months of 2024, illustrates the success of this strategy, showing a 5.6% organic growth.
Future Revenue Growth Projections
Revenue growth projections are optimistic, with organic sales growth expected to reach 8.5% for 2024. The company is also targeting a compound annual growth rate (CAGR) of 4-6% in net sales over the next five years, driven by its strategic initiatives.
Competitive Advantages
Colgate-Palmolive's competitive advantages include a strong global brand portfolio, extensive distribution networks, and a commitment to sustainability. The gross profit margin improved to 61.1% in Q3 2024, up from 58.5% in Q3 2023, reflecting improved operational efficiencies and pricing strategies. Such strong margins enable the company to invest further in growth initiatives.
Strategic Initiatives and Partnerships
The company has undertaken several strategic initiatives aimed at enhancing its market position. The 2022 Global Productivity Initiative aims to streamline operations and reduce costs, with total annualized pretax savings expected to be around $125 million once fully implemented. Additionally, increased advertising investment, which rose by 17% in absolute terms to $2.072 billion in the first nine months of 2024, supports brand awareness and market penetration efforts.
| Segment | Net Sales (2024) | Organic Sales Growth | Operating Profit Margin |
|---|---|---|---|
| Oral, Personal and Home Care | $11.814 billion | 9.3% | 26.5% |
| Hill’s Pet Nutrition | $3.342 billion | 5.6% | 22.9% |
| Total Company | $15.156 billion | 8.5% | 21.7% |
The data reflects the company's robust performance across its various segments, highlighting the areas where growth initiatives are expected to yield significant returns in the coming years.
Colgate-Palmolive Company (CL) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Colgate-Palmolive Company (CL) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Colgate-Palmolive Company (CL)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Colgate-Palmolive Company (CL)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.